Compare Continuous Gastrocnemius Plane Block With Intravenous Analgesia After Foot and Ankle Surgery
Foot Ankle Injuries
About this trial
This is an interventional treatment trial for Foot Ankle Injuries focused on measuring nerve block, Continuous Gastrocnemius plane block
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing elective foot and ankle surgery
- Patient informed consent was obtained
- Age 18 to 65 years Sex is not limited
- American Society of Anesthesiologists(ASA)Ⅰ~Ⅲ level
- Body Mass Index(BMI)18~28kg/m2
Exclusion Criteria:
- Puncture site infection
- Abnormal coagulation function
- Local anesthetic allergy
- Severe cardiopulmonary disease
- Liver and renal insufficiency
- Medical history of chronic pain
- Long-term use of sedative and analgesic drugs
- Communication disorders
- The operation time exceeded 3 hours
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Experimental group: Ropivacaine-controlled analgesia pump
Control group: oxycodone-controlled analgesia pump
A single injection of 0.375% Ropivacaine 15 milliliters was given into the common peroneal nerve, medial sural cutaneous nerve, and lateral sural cutaneous nerve. Than,a catheter was placed in the gastrocnemius plane, and a 0.125% ropivacaine-controlled analgesic pump was applied.(The formulation was 0.125% ropivacaine at 300 milliliters, with a background dose of 3 milliliters/hours, a patient-controlled analgesia(PCA) dose of 8 milliliters, and a locking time of 25 minutes.)
No treatment was given preoperatively, and postoperative oxycodone patient-controlled intravenous analgesia(PCIA). After awakening, intravenous oxycodone was titrated according to numerical rating scale(NRS) score, providing analgesia without background dose of oxycodone patient-controlled intravenous analgesia(PCIA) pump (single dose 1 milligram, locking time 5 minutes, 14 hours limit 12 milligrams)